Teduglutide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 342 publications

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

Journal: Bioconjugate chemistry

Published: April 10, 2026

Real-world experience of teduglutide for the treatment of short bowel syndrome-associated intestinal failure.

Real-world experience of teduglutide for the treatment of short bowel syndrome-associated intestinal failure.

Journal: Clinical nutrition ESPEN

Published: April 02, 2026

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Journal: Current opinion in gastroenterology

Published: March 23, 2026

Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)

Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)

Journal: Zeitschrift fur Gastroenterologie

Published: February 11, 2026

Growth trajectories of children with short bowel syndrome during the first year of teduglutide treatment.

Growth trajectories of children with short bowel syndrome during the first year of teduglutide treatment.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: February 06, 2026

Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence.

Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence.

Journal: Journal of clinical medicine

Published: February 04, 2026

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome.

Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome.

Journal: Intestinal Failure (New York, N.Y.)

Published: January 19, 2026

Interpreting pooled GLP-2 analogue effects in chronic intestinal failure transparency, attrition, and real-world generalisability.

Interpreting pooled GLP-2 analogue effects in chronic intestinal failure transparency, attrition, and real-world generalisability.

Journal: Clinical nutrition ESPEN

Published: January 17, 2026

Beyond intestinal failure: Expanding therapeutic frontiers of glucagon-like peptide-2 in gastrointestinal disease.

Beyond intestinal failure: Expanding therapeutic frontiers of glucagon-like peptide-2 in gastrointestinal disease.

Journal: World journal of gastrointestinal pharmacology and therapeutics

Published: January 13, 2026

From childhood to adulthood in chronic intestinal failure: A nationwide study.

From childhood to adulthood in chronic intestinal failure: A nationwide study.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: January 13, 2026

Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome.

Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome.

Journal: World journal of gastrointestinal pharmacology and therapeutics

Published: November 28, 2025

Clinical outcomes of teduglutide therapy in children with short bowel syndrome-associated intestinal failure: A single-center experience.

Clinical outcomes of teduglutide therapy in children with short bowel syndrome-associated intestinal failure: A single-center experience.

Journal: Intestinal Failure (New York, N.Y.)

Published: November 25, 2025

Showing 1-12 of 342

Last Updated: 06/30/2026